Acceleration of RAD204 Phase 1 dose escalation trial

by admin May 12, 2025

May 12, 2025

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Google +Pinterest

Danielle DiMartino Booth: US Economy at Precipice —...

Falcon Recieves Drill Permit Approval at Great Burnt...

7 Basic Copper Facts for Investors (Updated 2023)

BPH Energy LimitedPEP11 Update Federal Court Judicial Review

Dynasty Gold Begins Phase Two 2024 Drilling at...

Pink Bark: Rare Earth, Kaolin and Uranium Potential

CanAlaska Confirms Uranium Mineralization of 0.27% U3O8 on...

FDA Finds Kratom Capsules Safe, but Questions About...

Ramp Metals Provides Drilling Update and Confirms Copper-Zinc...

5 Top Weekly TSX Stocks: Sierra Metals Takes...

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Latest

4th round of US-Iran talks ends as Trump set to embark on...
Missiles, drones and airstrikes, until a sudden ceasefire. How India and Pakistan agreed to an uneasy truce
In China, some see the ghost of Mao as Trump upends America and the world
Pope! Amigo! Peruvians remember the young American priest who became pope
Dozens of boxes of Nazi materials found in basement at top Argentinian court

Categories

Business (1,634)
Investing (4,793)
Politics (7,566)
Uncategorized (2)
World (6,164)

About us
Contacts
Privacy Policy
Terms & Conditions
Email Whitelisting

Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Back To Top

Acceleration of RAD204 Phase 1 dose escalation trial

Multiple New Multi-Commodity Targets

A bridge builder and quiet reformer. How Pope Leo will lead the Catholic Church

You may also like